Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-17-008952
Filing Date
2017-08-28
Accepted
2017-08-28 17:19:40
Documents
2
Period of Report
2017-04-30
Effectiveness Date
2017-08-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A schedule14aproxy2017.htm DEF 14A 437589
2 proxycardinfoa01.jpg GRAPHIC 5043
  Complete submission text file 0001628280-17-008952.txt   446047
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-11504 | Film No.: 171055418
SIC: 2836 Biological Products, (No Diagnostic Substances)